Drug application
AZO GANTRISIN (PHENAZOPYRIDINE HYDROCHLORIDE, SULFISOXAZOLE)
Drugs@FDA NDA 019358 · ROCHE
Key facts
| Drug name | AZO GANTRISIN |
|---|---|
| Active ingredients | PHENAZOPYRIDINE HYDROCHLORIDE, SULFISOXAZOLE |
| Application type | NDA |
| Application number | 019358 |
| Company | ROCHE |
| Dosage forms | TABLET, ORAL |
| Strength | 50MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 6 - New Indication (no longer used) |
| Latest submission status date | Aug 31, 1990 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.